Neuraxis Inc. (NYSE AMERICAN: NRXS) Stock Information | RedChip

Neuraxis Inc. (NYSE AMERICAN: NRXS) Listen to this Section


$3.14
+0.0050 ( +0.16% ) 1.8K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 18 Feb 15, 2024
4 Insider transactions 1 Feb 14, 2024
8-k 8K-related 17 Jan 31, 2024
4 Insider transactions 1 Jan 23, 2024
8-k 8K-related 12 Dec 19, 2023
3 Insider transactions 2 Dec 13, 2023
10-q Quarterly Reports 94 Nov 20, 2023
nt Quarterly Reports 1 Nov 14, 2023
8-k 8K-related 15 Nov 14, 2023
10-q Quarterly Reports 88 Sep 22, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.